Breaking News, Collaborations & Alliances

Lonza, Crucell Ink Permexcis Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lonza and Crucell have entered into a co-exclusive manufacturing, sales and distribution agreement related to the Permexcis cell culture medium developed by Crucell for PER.C6 cells. Under this agreement, Lonza will manufacture the medium, and in addition will market and sell it on a global basis. Financial details of the agreement were not disclosed. The Permexcis medium is a chemically defined cell culture medium that does not contain human- or animal-derived components. Permexcis medium wa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters